Aimed at pathologists and oncologists, this unbranded leave behind focuses on the importance of using broad molecular profiling for mNSCLC (metastatic non-small cell lung cancer) patients. The visual challenge was to crate a unique look that avoids the brand colors and fonts of two different treatments as well as appearing different from the Novartis lung portfolio look.
Molecular Profiling
Previous
Previous
Condo Hoax
Next
Next